BioGend Therapeutics Co., Ltd. (TPEX: 6733)
Taiwan
· Delayed Price · Currency is TWD 37.00
+0.40 (1.09%)
Sep 11, 2024, 9:20 AM CST
BioGend Therapeutics Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Cash & Equivalents | 155.68 | 330.51 | 163.64 | 136.32 | 120.04 | 89.77 | Upgrade
|
| Short-Term Investments | 500 | 393.76 | 329.76 | 552.96 | 392.99 | 280 | Upgrade
|
| Cash & Short-Term Investments | 655.68 | 724.27 | 493.4 | 689.28 | 513.03 | 369.77 | Upgrade
|
| Cash Growth | -17.42% | 46.79% | -28.42% | 34.36% | 38.74% | -15.99% | Upgrade
|
| Accounts Receivable | 36.45 | 26.69 | 11.27 | 5.05 | 0.28 | 0.31 | Upgrade
|
| Other Receivables | 31.53 | 30.67 | 28.25 | 23.61 | 21.62 | 0.6 | Upgrade
|
| Receivables | 67.98 | 57.36 | 39.52 | 28.66 | 21.89 | 0.91 | Upgrade
|
| Inventory | 16.28 | 16.55 | 4.9 | 9.03 | 10.41 | 2.51 | Upgrade
|
| Prepaid Expenses | 2.18 | 3 | 4.07 | 7.57 | 1.42 | 22.08 | Upgrade
|
| Total Current Assets | 742.11 | 801.18 | 541.89 | 734.54 | 546.75 | 395.27 | Upgrade
|
| Property, Plant & Equipment | 53.42 | 56.2 | 34.01 | 8.89 | 5.94 | 8.74 | Upgrade
|
| Long-Term Investments | 19.4 | 20.34 | 10 | - | 69.43 | 83.66 | Upgrade
|
| Goodwill | 17.09 | 17.09 | 17.09 | 17.09 | - | - | Upgrade
|
| Other Intangible Assets | 134.48 | 151.04 | 210.95 | 261.92 | 102.29 | 118.97 | Upgrade
|
| Other Long-Term Assets | 5.78 | 4.64 | 7.89 | 1.42 | 0.94 | 0.62 | Upgrade
|
| Total Assets | 972.28 | 1,050 | 821.82 | 1,024 | 725.34 | 607.26 | Upgrade
|
| Accounts Payable | 2.03 | 2.16 | 2.08 | 0.49 | 1.36 | 1.07 | Upgrade
|
| Accrued Expenses | 7.99 | 25.22 | 17.22 | 14.39 | 14.19 | 11.96 | Upgrade
|
| Current Portion of Leases | 3.66 | 3.65 | 3.49 | 3.94 | - | - | Upgrade
|
| Other Current Liabilities | 10.9 | 15.22 | 9.07 | 6.3 | 2.72 | 2.47 | Upgrade
|
| Total Current Liabilities | 24.57 | 46.25 | 31.86 | 25.13 | 18.27 | 15.49 | Upgrade
|
| Long-Term Leases | 7.58 | 9.44 | 12.28 | 0.48 | - | - | Upgrade
|
| Long-Term Unearned Revenue | - | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 31.32 | 35.52 | 43.92 | 52.31 | - | - | Upgrade
|
| Total Liabilities | 63.48 | 93.71 | 90.56 | 80.42 | 20.77 | 17.99 | Upgrade
|
| Common Stock | 1,243 | 1,231 | 1,031 | 1,031 | 920 | 820 | Upgrade
|
| Additional Paid-In Capital | - | - | - | 212.85 | 160.9 | 301.11 | Upgrade
|
| Retained Earnings | -327.69 | -281.85 | -325.52 | -353.91 | -376.33 | -531.84 | Upgrade
|
| Comprensive Income & Other | -9.03 | -7.96 | -2.38 | -2.16 | - | - | Upgrade
|
| Total Common Equity | 905.84 | 940.96 | 702.86 | 887.54 | 704.57 | 589.26 | Upgrade
|
| Minority Interest | 2.96 | 15.81 | 28.4 | 55.91 | - | - | Upgrade
|
| Shareholders' Equity | 908.81 | 956.77 | 731.27 | 943.45 | 704.57 | 589.26 | Upgrade
|
| Total Liabilities & Equity | 972.28 | 1,050 | 821.82 | 1,024 | 725.34 | 607.26 | Upgrade
|
| Total Debt | 11.23 | 13.09 | 15.77 | 4.42 | - | - | Upgrade
|
| Net Cash (Debt) | 644.44 | 711.18 | 477.64 | 684.86 | 513.03 | 369.77 | Upgrade
|
| Net Cash Growth | -17.38% | 48.90% | -30.26% | 33.49% | 38.74% | -15.99% | Upgrade
|
| Net Cash Per Share | 5.24 | 5.91 | 4.63 | 6.76 | 5.87 | 4.55 | Upgrade
|
| Filing Date Shares Outstanding | 124.26 | 123.08 | 103.08 | 103.08 | 92 | 82 | Upgrade
|
| Total Common Shares Outstanding | 124.26 | 123.08 | 103.08 | 103.08 | 92 | 82 | Upgrade
|
| Working Capital | 717.54 | 754.93 | 510.03 | 709.42 | 528.47 | 379.78 | Upgrade
|
| Book Value Per Share | 7.29 | 7.65 | 6.82 | 8.61 | 7.66 | 7.19 | Upgrade
|
| Tangible Book Value | 754.28 | 772.83 | 474.82 | 608.52 | 602.28 | 470.3 | Upgrade
|
| Tangible Book Value Per Share | 6.07 | 6.28 | 4.61 | 5.90 | 6.55 | 5.74 | Upgrade
|
| Machinery | 31.28 | 31.19 | 24.66 | 24.55 | 23.87 | 24.67 | Upgrade
|
| Construction In Progress | - | 37.57 | 14.91 | - | - | - | Upgrade
|
| Leasehold Improvements | 37.91 | 0.34 | 0.34 | 0.34 | 3.03 | 3.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.